The Headache Inducing Effects of Cilostazol on Migraine Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 14
- 试验地点
- 1
- 主要终点
- The incidens of headache or migraine after adminstration of Cilostazol in migraine patients compared to placebo.
研究概览
简要总结
We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Health Services Research
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 60 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with migraine without aura according to the IHS criteria from
- •Healthy besides migraine
排除标准
- •Tension-type headache more than 3 days per month
- •Other types of primary headaches
- •Pregnancy
- •History of vascular diseases or psychiatric diseases.
研究组 & 干预措施
Cilostazol
Capsule of Cilostazol 200 mg are taken orally on each study day
干预措施: Cilostazol (Drug)
Placebo
A capsule of placebo containing starch are taken orally on each study day.
干预措施: Placebo (Drug)
结局指标
主要结局
The incidens of headache or migraine after adminstration of Cilostazol in migraine patients compared to placebo.
时间窗: Outcome measure will be done within 3 month. Final data will be presented within 6 months
Rectruitment of 14 patients will be done during April and May. Experiments will be carried out in May and June. Each experiment day takes 1½ hour. Data analysis will be done in June and July. Final data will be presented within 6 months.
次要结局
未报告次要终点
